Skip to content

English
Français

Careers
Contact Us

About DBV
- Overview
- Leadership
Our Pipeline
- Overview
- Clinical Trials
- VIASKIN^® peanut patch
- VIASKIN^® milk patch
- VIASKIN^® milk patch for EoE
- Expanded Access Program
Our Science
Investors
Newsroom
- Press Releases
- Media Kit

News

News

Select Year
Search News

Found 496 Results

Page 35 of 50« First «...10 20 30...33 343536 37...40 50...»Last »

June 15, 2016

Late-Breaking Presentation at EAACI Highlights Viaskin^® Peanut Data Providing Biomarker Insights for Monitoring Treatment Progression

June 13, 2016

DBV Technologies Announces Publication of Preclinical Data in JACI Suggesting EPIT^® Provides Sustained Protection Against Anaphylaxis

June 7, 2016

DBV Technologies Announces Appointment of Leading Japanese Allergist, Dr. Motohiro Ebisawa, to its Scientific Advisory Board

June 1, 2016

DBV Technologies Data at EAACI 2016 Highlight Its Expansive Product Development in Food Allergies

May 31, 2016

DBV Technologies and Nestlé Health Science Form Collaboration to Develop and Commercialize a Novel Diagnostic Test for Pediatric Milk Allergy

May 30, 2016

Mixed General Assembly of June 21, 2016 Procedures for obtaining preparatory documents for the Assembly

May 20, 2016

DBV Technologies to Attend Upcoming Investor Conferences

April 29, 2016

DBV Technologies Reports March 31, 2016 Cash Position

April 28, 2016

DBV Technologies Announces Filing of 2015 “Document de Référence” and 2015 Annual Report on Form 20-F

April 27, 2016

DBV Technologies to Attend Upcoming Investor Conferences

Page 35 of 50« First «...10 20 30...33 343536 37...40 50...»Last »

Investor Relations Contact

Jonathan Neely

+1 848-388-4584

jonathan.neely@dbv-technologies.com

Media Contact

Brett Whelan

+1 848-350-7622

brett.whelan@dbv-technologies.com

Subscribe to get the latest DBV press releases

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

Homepage
About DBV
Our Pipeline
Our Science
News
Investors
Careers
Contact Us

© 2026 DBV Technologies. All rights reserved.
Les traitements de DBV Technologies sont expérimentaux et ne sont pas approuvés par la FDA.

Terms of Use
Privacy Policy
Legal Notice
Your California Privacy Rights

Scroll to Top